93 related articles for article (PubMed ID: 7169574)
1. [Serum levels of carcinoembryonic antigen (CEA) and pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast cancer].
Kimoto A; Uemura K; Egami T; Kawaguchi H; Goto H; Miyauchi Y; Yokoyama I
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2022-8. PubMed ID: 7169574
[No Abstract] [Full Text] [Related]
2. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
[TBL] [Abstract][Full Text] [Related]
3. Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA).
Anderson JM; Stimson WH; Gettinby G; Jhunjhunwala SK; Burt RW
Eur J Cancer (1965); 1979 May; 15(5):709-14. PubMed ID: 510333
[No Abstract] [Full Text] [Related]
4. Pregnancy-associated plasma protein A and extensive necrosis. Clinically significant predictors of early recurrence in stage I estrogen receptor-negative breast carcinoma.
Kuhajda FP; Eggleston JC
Lab Invest; 1985 Jul; 53(1):101-7. PubMed ID: 2409349
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
6. [The tumor markers TPA and CEA in the after care of breast cancer].
Beaufort F; Fueger GF; Steiner H
Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
[TBL] [Abstract][Full Text] [Related]
8. A comparison between pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG), carcino-embryonic antigen (CEA), CA-125, and CA-15-3 as tumor markers in breast cancer.
Bersinger NA; Rageth JC
Eur J Gynaecol Oncol; 1990; 11(2):135-9. PubMed ID: 2379513
[TBL] [Abstract][Full Text] [Related]
9. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
[TBL] [Abstract][Full Text] [Related]
10. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
11. Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy.
Lamerz R; Ruider H
Bull Cancer; 1976; 63(4):575-86. PubMed ID: 1021185
[No Abstract] [Full Text] [Related]
12. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
Villani C
Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
[TBL] [Abstract][Full Text] [Related]
13. [Changes in carcinoembryonic antigen in patients with breast cancer].
Papaleo G; Zito GA; Gambardella A; Colella C
Boll Soc Ital Biol Sper; 1982 Dec; 58(23):1577-81. PubMed ID: 7165764
[TBL] [Abstract][Full Text] [Related]
14. [Behavior of some tumor markers (secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein, circulating immune complexes in the serum of patients with breast tumors].
Briese V; Strache RR; Büttner HH; Kunze M; Brock J; Röpcke G
Zentralbl Gynakol; 1987; 109(5):265-73. PubMed ID: 3591061
[TBL] [Abstract][Full Text] [Related]
15. [A clinicopathological study on carcinoembryonic antigen in breast cancer].
Asagoe T; Yamoto H; Hanatani Y; Horie F; Nemoto A; Kidooka K; Shikata J
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):793-8. PubMed ID: 2370434
[TBL] [Abstract][Full Text] [Related]
16. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of carcinoembryonic antigen level of serum and tumor tissue in breast cancer patients (author's transl)].
Kitamura M; Tominaga T; Kaneko H; Hayashi K; Takahashi I; Saito T; Ito I
Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):35-43. PubMed ID: 6267147
[No Abstract] [Full Text] [Related]
18. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen (CEA): its role as a tumour marker in breast cancer.
Doyle PJ; Nicholson RI; Groome GV; Blamey RW
Clin Oncol; 1981 Mar; 7(1):53-8. PubMed ID: 7214765
[No Abstract] [Full Text] [Related]
[Next] [New Search]